Form 4: Cboe Global Markets Executive Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Catherine R. Clay, EVP of Global Derivatives at Cboe Global Markets, sold 3,598 shares of common stock for $226.58 per share on May 23, 2025, pursuant to a Rule 10b5-1 trading plan.
Summary
- Catherine R. Clay, the Executive Vice President of Global Derivatives at Cboe Global Markets, Inc. (CBOE), reported a sale of company common stock.
- The transaction involved the disposition of 3,598 shares of CBOE common stock.
- The shares were sold at a price of $226.58 per share.
- The sale occurred on May 23, 2025.
- Following this transaction, Catherine R. Clay directly beneficially owns 2,183 shares of CBOE common stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on February 19, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a Rule 10b5-1 plan mitigates concerns about opportunistic selling and indicates compliance with corporate governance best practices.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which demonstrates adherence to insider trading compliance policies and reduces the perception of opportunistic selling.
- The transaction reflects a planned liquidity event for the executive rather than an immediate reaction to new information.
Negatives
- An insider sale, even if pre-planned, results in a reduction of the executive's direct ownership stake in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a routine disclosure of an insider stock transaction for an executive at a major global exchange operator. Such transactions are common and often pre-scheduled, especially for senior executives, to manage personal finances while adhering to strict insider trading regulations.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was conducted under a Rule 10b5-1 trading plan, adopted on February 19, 2025. This plan allows insiders to sell shares at a predetermined time or price, providing an affirmative defense against insider trading allegations. | 02/19/2025 | This demonstrates the company's and the executive's commitment to robust corporate governance and compliance with SEC regulations regarding insider trading. |
Stakeholder Impact
- Shareholders: The sale represents a minor reduction in direct insider ownership, but its execution under a 10b5-1 plan suggests it is a routine personal financial management event rather than a signal of management's view on the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date when the Rule 10b5-1 trading plan was adopted by Catherine R. Clay. |
| 05/23/2025 | Date of the reported transaction (sale of common stock). |
| 05/28/2025 | Date the Form 4 filing was signed and submitted. |
Keywords
Cboe Global Markets, CBOE, Insider Trading, Form 4, Stock Sale, Executive Compensation, 10b5-1 Plan, Derivatives, Exchange Operator
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.